pdf download button

November 2017

MedAnnex partners with University College London (UCLC) to further explore annexuzlimab’s potential as a new therapeutic for SLE

pdf download button

November 2017

MedAnnex confirms a 4-year Medical Research Scotland PhD studentship (Glasgow University), exploring the role of annexin and mechanism of action of annexuzlimab in chronic inflammatory disease

pdf download button

November 2017

MedAnnex welcomes Alejandra Rodriguez Sosa MSc (a recent graduate in Drug Design and Biomedical Science) to the team, via the Santander intern scheme

pdf download button

November 2017

MedAnnex attends 14th annual bioProcess UK Conference in Cardiff – “Delivering innovations to patients”.

pdf download button

November 2017

MedAnnex’s MD Tina Flatau facilitates panel discussion on “Patient Centricity” at Pharma Integrates 2017 in London

pdf download button

October 2017

Medannex is now one of the Cambridge Milner Institute’s 39 affiliated companies, joining the likes of Amgen and Cancer Research Technologies in Milner’s therapeutically-focused science community.

pdf download button

October 2017

Medannex commits to sustainability, equality and innovation by signing the Scottish Business Pledge.

pdf download button

September 2017

Medannex endorses the BIA’s stance on Brexit: remain hand in hand with the EU on regulation, avoid imposing new tariffs, maintain efficient recruitment and allow collaborations and funding mechanisms to continue.

pdf download button

September 2017

Medannex welcomes new intern Anusha Regupathy (MSc pharmaceutical student, Napier University) via the Santander Internship Scheme.

pdf download button

September 2017

Medannex joins the UK BioIndustry Association (BIA) which represents the UK bioscience sector in Westminster, Whitehall and beyond.

pdf download button

August 2017

Medannex begins collaboration with Glasgow University’s Institute of Infection, Immunity and Inflammation, to further investigate annexuzlimab’s potential.

pdf download button

June 2017

Medannex welcomes Dr Fiona Dempsey (formerly of CAT, Charles River and the Cellular Bioprocessing Group at Heriot-Watt University) as Director of Scientific Operations.

pdf download button

May 2017

Medannex joins fellow OBN members at London’s Biotrinity 2017 partnering event.

pdf download button

May 2017

MedAnnex attends 10th Global Discovery to Innovation Forum for pharmaceutical R&D experts.

pdf download button

May 2017

MSc medical biotechnologist Scott Crichton joins Medannex as Associate Study Manager.

pdf download button

May 2017

Medannex joins the OBN life sciences network.

pdf download button

April 2017

Medannex's trademark for annexuzlimab is now registered in Brazil.

pdf download button

February 2017

Medannex leads workshop at Edinburgh University School of Biological Sciences' Student Industry Meeting.

pdf download button

January 2017

MedAnnex Limited is seeking to appoint a part–time Biology Study Manager.

pdf download button

November 2016

Scottish biotechnology companies to chair expert panel session at Pharma Integrates.

pdf download button
pdf download button

October 2016

Dr Henry Hays joins MedAnnex as Scientific Project Manager.

May 2016

MedAnnex attends the BioDundee Conference.

pdf download button

March 2016

MedAnnex Ltd is seeking to appoint a part-time Project Manager.

pdf download button

February 2016

Rare Disease Day 2016.

pdf download button

January 2016

MedAnnex to receive Scottish Enterprise funding.

pdf download button

January 2016

MedAnnex announces Dr Tina Flatau as Managing Director.

pdf download button

December 2015

MedAnnex secures further investment for the development of its novel monoclonal antibody to treat autoimmune diseases.

pdf download button

November 2015

MedAnnex attends the American College of Rheumatology Conference.

pdf download button

October 2015

MedAnnex expands to new facilities at TechCube Edinburgh.

pdf download button

December 2013

MedAnnex and China Summit Capital partner to develop next generation monoclonal antibody for Chinese market.

pdf download button

August 2013

MedAnnex secures investment to expedite the development of its novel monoclonal antibody to treat autoimmune diseases.

pdf download button

August 2013

Alida Capital International announces completion of a funding round for the Scottish biotechnology company MedAnnex.